“Efficacy of Ibrutinib in the Treatment of Monoclonal Gammopathy of Renal Significance With C3 Deposits Secondary to Chronic Lymphocytic Leukemia”. 2025. Archives of Clinical and Biomedical Research 9 (5): 360-63. https://fortunejournals.org/ojs/index.php/acbr/article/view/15131.